Literature DB >> 15085969

Treatment of xanthelasma palpebrarum with argon laser photocoagulation. Argon laser and xanthelasma palpebrarum.

Emel Basar1, Halit Oguz, Hakan Ozdemir, Sehirbay Ozkan, Hasim Uslu.   

Abstract

PURPOSE: We report the results of argon laser coagulation of xanthelasma lesions.
METHODS: Forty eyelids of 24 patients with xanthelasma were treated in 1 to 4 sessions at 2-3 week intervals, using an argon green laser. The laser parameters were as follows: wavelength 514 nm; spot size 500 microns; energy 900 mW; the duration of the laser pulse 0.1-0.2 seconds. The procedure was done on outpatient basis. A gauze pad soaked in topical anaesthetic eye drops was applied to the surface of the lesion.
RESULTS: The therapy was well tolerated, and all lesions responded to the therapy. There were no complications and no functionally relevant scar developed. The cosmetic outcome was considered to be good in 85% of the cases.
CONCLUSION: Argon laser photocoagulation represents an alternative treatment in selected cases. It is easy to perform and well tolerated by the patients.

Entities:  

Mesh:

Year:  2004        PMID: 15085969     DOI: 10.1023/b:inte.0000018523.55861.6c

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  10 in total

1.  Histology of xanthelasma lesion treated by argon laser photocoagulation.

Authors:  R Sampath; D Parmar; I A Cree; J R Collin
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

2.  Treatment of xanthelasma palpebrarum with the pulsed dye laser.

Authors:  M P Schönermark; C Raulin
Journal:  Lasers Surg Med       Date:  1996       Impact factor: 4.025

3.  Treatment of xanthelasma with Solcoderm.

Authors:  M Ronnen; S Suster; M Huszar; E Gilad
Journal:  J Am Acad Dermatol       Date:  1989-10       Impact factor: 11.527

4.  Xanthelasma in association with hyperthyroidism.

Authors:  G R Martinez-Rovira
Journal:  JAMA       Date:  1968-10-28       Impact factor: 56.272

5.  The use of CO2 laser for the treatment of xanthelasma palpebrarum.

Authors:  Y Ullmann; Y Har-Shai; I J Peled
Journal:  Ann Plast Surg       Date:  1993-12       Impact factor: 1.539

6.  [Blepharoplasty with special reference to correction of xanthelasma].

Authors:  M Deutinger; H Koncilia; G Freilinger
Journal:  Handchir Mikrochir Plast Chir       Date:  1993-05       Impact factor: 1.018

7.  A three-year experience with the argon laser in dermatotherapy.

Authors:  M Landthaler; D Haina; W Waidelich; O Braun-Falco
Journal:  J Dermatol Surg Oncol       Date:  1984-06

Review 8.  Dyslipoproteinemia and xanthomatosis.

Authors:  C Haber; P O Kwiterovich
Journal:  Pediatr Dermatol       Date:  1984-04       Impact factor: 1.588

9.  Xanthelasma: follow-up on results after surgical excision.

Authors:  B C Mendelson; J K Masson
Journal:  Plast Reconstr Surg       Date:  1976-11       Impact factor: 4.730

10.  [Argon laser coagulation of xanthelasmas].

Authors:  C Hintschich
Journal:  Ophthalmologe       Date:  1995-12       Impact factor: 1.059

  10 in total
  4 in total

1.  Argon laser-assisted treatment of benign eyelid lesions.

Authors:  Şafak Korkmaz; Feyzahan Ekici; Sabahattin Sül
Journal:  Lasers Med Sci       Date:  2015-01-07       Impact factor: 3.161

2.  Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum.

Authors:  Mona Abdelkader; Shereen Ezzelregal Alashry
Journal:  Saudi J Ophthalmol       Date:  2014-11-20

Review 3.  Xanthelasma: An Update on Treatment Modalities.

Authors:  Zainab Laftah; Firas Al-Niaimi
Journal:  J Cutan Aesthet Surg       Date:  2018 Jan-Mar

4.  Modified argon laser therapy for benign tumor of the eyelid.

Authors:  Jisang Han; Shin-Hyo Lee; Chul Young Choi; Ramin Khoramnia; Jaemin Kim; Hyun Jin Shin
Journal:  BMC Ophthalmol       Date:  2022-09-24       Impact factor: 2.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.